Pathological or at Risk Gambling Clinical Trial
Official title:
Transversal Multiaxial Evaluation and 5-year Follow-up of a Cohort of French Gamblers.
Verified date | February 2018 |
Source | Nantes University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is divided into two stages. The first stage is a transversal study and corresponds to the recruitment of participants, which will last about two years. Three groups of gamblers will be constituted : Non-problematic gamblers (NPG), Problematic gamblers Not in Care (PGNC) and Problematic gamblers in Care (PGC).The second stage is a prospective 5-year follow-up study of the cohort (only the initial NPG and PGNC groups are concerned by the follow-up study), that consists on an annual follow-up evaluation. The main objective of the first stage of the study is to compare the characteristics of the three groups of gamblers on some socio-demographic and clinical data. These comparisons will allow us to identify, among all data, those that will be most likely to explain the evolution of the practice of gambling (appearance or resolution of a gambling problem), and recourse to specific care. These such isolated data will be tested in the second stage of the study, in order to determine those that are predictive factors of three steps of the gambling course of some gamblers : evolution of a controlled gambling practice into a problematic gambling practice, resolution of the problematic gambling practice without intervention of care, and first recourse to specific care.
Status | Completed |
Enrollment | 641 |
Est. completion date | September 2016 |
Est. primary completion date | November 2011 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - To be 18 to 65 years old - To have gambled during the last year - To gamble at least one time a year Exclusion Criteria: - To be under tutelage (a French protecting measure for persons with altered judgement) - To present obvious cognitive disturbances - To have difficulties to read and/or write in French language |
Country | Name | City | State |
---|---|---|---|
France | Bordeaux University Hospital | Bordeaux | |
France | Clermont Ferrand university Hospital | Clermont Ferrand | |
France | Louis Mourier hospital | Colombes | |
France | Marseille University Hospital | Marseille | |
France | Nantes University Hospital | Nantes | |
France | Marmottan hospital | Paris | |
France | Paul Brousse hospital | Villejuif |
Lead Sponsor | Collaborator |
---|---|
Nantes University Hospital | MILDT |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of psychiatric comorbidities | The 10 psychiatric comorbidities explored by the MINI are major depressive episode, (hypo)-maniac episode, 5 anxiety disorders (panic disorder ± agoraphobia, social phobia, obsessional-compulsive disorder, PTSD, generalised anxiety disorder), substance use disorders (alcohol, other psychoactive substances), psychotic disorders, and eating disorders (anorexia nervosa and bulimia). | 5 years | |
Secondary | Socio-demographic data | gender, age, marital status, educational level, professional status, professional category, and level of income per month. | 5 years | |
Secondary | Clinical data | psychiatric and somatic comorbidities, personality disorders, gambling habits, diagnosis and severity of pathological gambling, level of cognitive distortions, ADHD in childhood and adulthood, temperament and character.Each of these data is measured at the initial evaluation (at time of recruitment), and then each year during the time of follow-up (5 years). | 5 years |